Literature DB >> 17217853

Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

J David Spence1.   

Abstract

Patients at high risk of vascular events can reduce their risk by 75% to 80% through a combination of lifestyle changes and medical therapy. These include smoking cessation, a Mediterranean diet, daily exercise, maintaining a fit weight, moderate consumption of alcohol, effective control of blood pressure and diabetes, intensive treatment with lipid-lowering drugs and antiplatelet agents, and perhaps treatment with vitamins to lower homocysteine. Much of this is achieved primarily by the patient; physicians need to become better at assisting their patients in making lifestyle changes. Effective control of treatment-resistant hypertension can be improved by individualizing medical therapy to the underlying cause, based on measurement of plasma renin and aldosterone. Measurement of carotid plaque may be useful by providing feedback on the success of therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217853     DOI: 10.1007/s11910-007-0020-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  86 in total

1.  What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L.

Authors:  D G Hackam; J C Peterson; J D Spence
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

2.  Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy.

Authors:  J David Spence; Michael Eliasziw; Maria DiCicco; Daniel G Hackam; Ramzy Galil; Tara Lohmann
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

3.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Authors:  B R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

4.  Drug interactions with grapefruit: whose responsibility is it to warn the public?

Authors:  J D Spence
Journal:  Clin Pharmacol Ther       Date:  1997-04       Impact factor: 6.875

5.  Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.

Authors:  E P Quinlivan; J McPartlin; H McNulty; M Ward; J J Strain; D G Weir; J M Scott
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

Review 6.  Mannheim intima-media thickness consensus.

Authors:  P-J Touboul; M G Hennerici; S Meairs; H Adams; P Amarenco; M Desvarieux; S Ebrahim; M Fatar; R Hernandez Hernandez; S Kownator; P Prati; T Rundek; A Taylor; N Bornstein; L Csiba; E Vicaut; K S Woo; F Zannad
Journal:  Cerebrovasc Dis       Date:  2004-11-02       Impact factor: 2.762

7.  Brisk walking, fitness, and cardiovascular risk: a randomized controlled trial in primary care.

Authors:  M A Tully; M E Cupples; W S Chan; K McGlade; I S Young
Journal:  Prev Med       Date:  2005-08       Impact factor: 4.018

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.

Authors:  Jari J Lilja; Mikko Neuvonen; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

10.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

View more
  3 in total

Review 1.  Therapeutic approaches to drug targets in atherosclerosis.

Authors:  Prasad G Jamkhande; Prakash G Chandak; Shashikant C Dhawale; Sonal R Barde; Priti S Tidke; Ram S Sakhare
Journal:  Saudi Pharm J       Date:  2013-11-05       Impact factor: 4.330

2.  Conformal mapping of carotid vessel wall and plaque thickness measured from 3D ultrasound images.

Authors:  Gary P T Choi; Yimin Chen; Lok Ming Lui; Bernard Chiu
Journal:  Med Biol Eng Comput       Date:  2017-06-07       Impact factor: 2.602

3.  Deep learning-based carotid media-adventitia and lumen-intima boundary segmentation from three-dimensional ultrasound images.

Authors:  Ran Zhou; Aaron Fenster; Yujiao Xia; J David Spence; Mingyue Ding
Journal:  Med Phys       Date:  2019-06-11       Impact factor: 4.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.